Sugar.fit, a health-tech start-up has announced its $11 million Series A funding round today. The funding was led by MassMutual Ventures with participation from existing investors including Cure.fit, Tanglin Venture Partners, and Endiya Partners. The fresh capital will be used to expand the company’s product offering, launch an offline presence, and accelerate research and development in the field of diabetes management, accelerating the brand’s footprint and growth, a statement issued by the company read. 

The company offers a diabetes care program by integrating a variety of devices such as continuous glucose monitors, fitness trackers, and other health diagnostics and providing easy access to diabetes specialists and health coaches. This enables users to track the real-time impact of their lifestyle on glucose levels, and receive personalised, timely guidance across the aspects of fitness, nutrition, and sleep from their care team. 

Madan Somasundaram, co-founder and CEO of Sugar.fit said, "This investment will enable us to further enhance our technology and expand our reach across India, ultimately helping more people take control of their diabetes and improve their health.” 

Anvesh Ramineni, managing partner at MassMutual Ventures said, "The team’s approach to diabetes management combines hardware, software, and analytics to deliver a personalised program and drive lasting behavioral change for better health outcomes. We believe Sugar.fit will transform the health of millions, while battling the increasing incidence of diabetes in India." 

Mukesh Bansal, founder of Cure.fit said, "We are very proud of the progress Sugar.fit has made in the last two years. This is the best team in this space with the strongest diabetes reversal metrics." 

Founded in 2021, Sugar.fit initially raised $10 million in a seed funding round and has since proven exceptional growth. In the last 18 months, the brand has witnessed eightfold growth in paid subscribers and currently serves more than 25,000 users on its platform.